logo
Generative AI is finding fertile soil in the healthcare industry

Generative AI is finding fertile soil in the healthcare industry

Fast Company5 hours ago

Bringing AI to the doctor's appointment
AI in healthcare is top of mind this week, thanks to a viral story on Reddit about a man who said ChatGPT saved his wife's life. She had undergone a cyst removal and wasn't feeling well, but was on an antibiotic and decided to 'wait it out.' After the man described her symptoms to ChatGPT, the chatbot advised him to take his wife to the ER. He did—and likely saved her life. Doctors diagnosed her with sepsis.
Stories like these aren't new. Over the past year, we've seen a number of 'ChatGPT-saved-my-life' anecdotes popping up online. Meanwhile, two-thirds of doctors now reportedly use ChatGPT to help them home in on a diagnosis, often with good results.
The models powering ChatGPT are trained on medical textbooks, research journal articles, medical guidelines, and health websites such as WebMD. That training gives them broad knowledge of anatomy, diseases, symptoms, treatment options, and drug interactions. OpenAI also fine-tuned the models by using feedback from health professionals. While AI models—even highly specialized ones—can't yet replace human doctors, researchers are working hard to improve their accuracy and reliability.
AI is also having an immediate impact in clinical documentation—an area that's long been a pain point for doctors. Many physicians—especially primary care doctors—spend an extra 90 minutes to three hours per day completing patient records. Combined with the pressure to see more patients, this contributes heavily to burnout.
Increasingly, health systems are deploying 'AI scribes' to ease this burden. Such tools can record a patient encounter and generate summaries for the electronic medical record (EMR). The Cleveland Clinic, for example, implements a clinical documentation and point-of-care coding solution from San Francisco-based Ambience. Using Ambience's app (which itself is powered by OpenAI models), the clinician records a patient visit, reviews an AI-generated summary of everything discussed in the meeting (including the billing codes), then approves the notes for inclusion in the EMR.
According to Cleveland Clinic's chief digital officer Rohit Chandra, 4,000 of the organization's physicians are already using the tool. 'It makes their jobs a ton easier, and it makes the patient interactions a lot better because now patients actually engage with the doctor,' he says.
Looking ahead, AI scribes could go far beyond basic documentation. Future versions may be able to document a medical exam with full contextual knowledge of the patient's history (past problems and conditions, treatments, tests, and medications). 'We believe that with some work and attention, AI will become smart enough to understand the fullness of a patient's health journey, as opposed to just a discreet encounter,' Chandra says.
For example, if a new condition arises during an exam, the AI might flag connections to prior complaints or lab results. It could help a physician prescribe new medications and guard against bad interactions in patients who may already be taking multiple drugs. The AI can also prepare a 'pre-read' for the clinician: a summary of a patient's current complaint—in the context of the individual's past history—that a physician (who may have already seen 10 patients that day) can read outside the door of the exam room.
'I'm hoping that we can keep building on the success that we've had so far to literally drive the documentation burden to zero,' Chandra says. 'If we do that well, we should eliminate a huge handicap that currently sits around our doctors, and we can bring the joy back to caregiving—that's a literal quote from a doctor.'
And with so much promise for easing physician burnout and improving patient care, investors are taking note. Ambience raised a $70 million B round in February 2024, co-led by Kleiner Perkins and OpenAI's Startup Fund, reportedly putting its valuation at $1 billion.
Ambience competes with Abridge, which performs a similar function of transcribing physician-patient conversations. Like Ambience, it has an integration with the popular Epic electronic medical records platform. Abridge recently raised $300 million in a Series E funding at a $5.3 billion valuation.
Health AI may have a breakout star in OpenEvidence
The healthcare industry moves very slowly, until it doesn't. A company called OpenEvidence is tackling clinical decision support—one of the most challenging areas in medicine—and appears so far to be winning over doctors at an impressive pace. In February, the Cambridge, Massachusetts-based company reported that 250,000 U.S. doctors were already using its product, and by mid-June the number had climbed to 350,000. Some industry observers say it's the fastest-growing platform for physicians in history. OpenEvidence recently closed a $75 million A round led by Sequoia Capital that pushed its valuation to $1 billion.
The product functions a bit like Perplexity, but for healthcare. It's an AI-powered search tool, along with a chatbot, that lets doctors keep asking questions until they get what they need. Specifically, the tool locates evidence-based medical information from peer-reviewed journals, then summarizes it to answer a given question. The platform searches across 35 million medical publications, and recently announced a strategic partnership with The New England Journal of Medicine, giving it access to decades of premium medical content. OpenEvidence also recently signed a multiyear deal with the JAMA Network that provides its AI tool with access to content from the network's 13 medical journals.
Unlike other platforms, OpenEvidence doesn't rely on random health information found on the open web. The outputs are grounded in trusted medical literature, and if the literature is inconclusive, OpenEvidence simply doesn't attempt an answer.
'One of the hardest things about being a doctor . . . is that they're expected to keep up with a fire hose of medical information,' said OpenEvidence CEO Daniel Nadler in a recent podcast. 'So this is really not appreciated by people who are not doctors, but there are two new medical papers published every minute, 24 hours per day.'
Hume AI's emotionally intelligent models are finding new applications in eldercare and mental health
There's growing evidence that, for many people using AI chatbots, one of the main attractions is companionship—often even a shoulder to cry on. For this to work well, a chatbot must have a reasonable amount of common sense (to help users keep their problems in perspective), but also strong emotional intelligence, especially empathy. New York-based Hume AI specializes in emotionally intelligent AI voice models. CEO Alan Cowen told me that these models enable a chatbot to detect the user's emotional state and respond appropriately. The models can also speak and listen simultaneously, allowing the AI to fully process what the user is saying—and know when to stop talking and simply listen.
One of the most compelling applications of Hume AI's emotionally intelligent AI voices is a smartphone app called EverFriends, which provides conversation and companionship to seniors struggling with isolation and loneliness. Grand Rapids-based EverFriends.ai, the app's developer, believes it's critical that the app can detect a user's mood and adapt its tone and responses accordingly. For users with dementia, the app can slow down its speech and repeat its outputs when needed. Along with companionship, EverFriends can help older users remember to take medications, attend appointments, and do home health routines such as balance exercises. And the app can automatically send out an emergency alert to caregivers or family if something goes wrong.
Hume also supplies the EQ AI behind a platform called Hpy, which is used by therapists. The platform serves as a 'scribe' by listening in on therapy sessions and generating comprehensive session notes, which cuts down on the time therapists must spend on documentation. While creating the notes, Hpy also draws on Hume's Expression Measurement API to detect emotional cues in the client's words—insights that may shape the therapist's approach. Finally, Hpy uses Hume's Empathic Voice Interface (EVI) to give clients an AI companion to talk to between sessions with the human therapist. Clients can have guided sessions with the AI voice to work on specific therapeutic goals, or just have an open conversation with the AI. The AI, in turn, is able to maintain a meaningful dialogue, thanks to its awareness of the client's needs from earlier sessions.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths
Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths

Yahoo

time16 minutes ago

  • Yahoo

Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths

Innovative Industrial Properties, Inc. (NYSE:IIPR) is one of the Best REIT Dividend Stocks to Buy in 2025. Aerial view of a large REIT building complex, its facade reflecting the city skyline. The company focuses on cannabis-related facilities, mainly grow houses, and operates under a net lease model where tenants handle most property expenses. As the cannabis industry shifts from rapid growth to consolidation, some tenants are struggling to pay rent. Despite these challenges, IIPR has managed to navigate the headwinds fairly well. One of Innovative Industrial Properties, Inc. (NYSE:IIPR)'s main strengths is its solid balance sheet, with a low debt ratio of 0.15, well below industry averages. This low leverage gives the company flexibility to expand its portfolio and support its dividend. From 2017 to 2024, its average AFFO payout ratio was around 85%, which is on the higher side for a net lease REIT. A recent lease adjustment with a major tenant is expected to reduce FFO by $0.16 per share, potentially pushing the payout ratio slightly above 90% in 2025. This makes Innovative Industrial Properties, Inc. (NYSE:IIPR)'s strong financial position even more important and helps justify its dividend yield of over 13%. Innovative Industrial Properties, Inc. (NYSE:IIPR) currently offers a quarterly dividend of $1.90 per share and has been growing its payouts for eight consecutive years. While we acknowledge the potential of IIPR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None.

Czechs drop surgery requirement for gender change
Czechs drop surgery requirement for gender change

Yahoo

time17 minutes ago

  • Yahoo

Czechs drop surgery requirement for gender change

PRAGUE (Reuters) -Czech transgender people will no longer be required to undergo a surgery but will need to be diagnosed as transsexual by specialist doctors and complete observation lasting usually six to 12 months to complete their transition, according to the Health Ministry's new guidelines. The guidelines issued on Thursday put in practice a Constitutional Court ruling, which last year struck down the surgery requirement. The ruling, which said the practice violated transgender people's rights for physical integrity and human dignity, moved the central European country in line with most European Union members and was welcomed by human rights activists. The decision struck down affected parts of the relevant law but did not replace it. The methodology issued on Thursday seeks to clarify the situation and give guidelines to medical professionals, the ministry said.

Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics
Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics

Yahoo

time17 minutes ago

  • Yahoo

Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics

The Supreme Court ruled Thursday that states may exclude Planned Parenthood clinics from providing medical screenings and other healthcare for women on Medicaid. The court's conservative majority cast aside the longstanding rule that said Medicaid patients may obtain medical care from any qualified provider. In a 6-3 vote, the justices ruled the Medicaid Act does not give patients an "individual right" to the provider of their choice. The dispute turned on abortion, even though federal funds cannot be used to perform the procedure. Medicaid is funded by the federal government and the states. For decades, conservative states have sought to "defund" Planned Parenthood and argued they did not want to subsidize a leading provider of abortions. But until recently, the federal government and most courts had held that Medicaid patients may go to any qualified provider for healthcare. The legal battle hinged on whether the Medicaid Act gave a patients a right that could be protected in court. The answer was no, said Justice Neil M. Gorsuch speaking for the majority. The court's three liberals, all women, dissented. Justice Ketanji Brown Jackson said the decision "will deprive Medicaid recipients in South Carolina of their only meaningful way of enforcing a right that Congress has expressly granted to them. And, more concretely, it will strip those South Carolinians — and countless other Medicaid recipients around the country — of a deeply personal freedom: the ability to decide who treats us at our most vulnerable." Justices Sonia Sotomayor and Elena Kagan agreed. In theory, a Medicaid patient could file a complaint with the Trump administration and tell the Department of Health and Human Services that the state is failing to comply fully with the Medicaid Act. Planned Parenthood clinics provide cancer screenings, birth control, medical screenings, pregnancy testing, contraception and other healthcare services. Congress pays most of the state's costs for Medicaid, and the law says "any individual eligible for medical assistance" may receive care from any provider who is "qualified to perform the service." Last year, the 4th Circuit Court of Appeals rejected South Carolina's contention that it could exclude Planned Parenthood from the Medicaid program. "We reaffirm that a Medicaid beneficiary may ... vindicate her right under the Medicaid Act to freely choose among qualified healthcare providers, of which Planned Parenthood is one," wrote Judge J. Harvie Wilkinson, a prominent conservative and a Reagan appointee. But the court agreed to hear the state's appeal in Medina vs. Planned Parenthood. Lupe Rodríguez, executive director of National Latina Institute for Reproductive Justice, called Thursday's decision "an attack on our healthcare and our freedom to make our own decisions about our bodies and lives. By allowing states to block Medicaid patients from getting care at Planned Parenthood health centers, the Court has chosen politics over people and cruelty over compassion." Sen. Dick Durbin (D-Ill.) said it was "yet another shameful ruling that inserts the government directly between a patient and their doctor — just like Dobbs three years ago and Skrmetti last week. Intimate, personal decisions about health care shouldn't require sign off from extremist politicians." He was referring to the 2022 decision that overturned Roe vs. Wade and last week's ruling upholding state laws that ban hormone treatment for transgender teens. Carol Tobias, president of the National Right to Life Committee, praised the decision as a landmark. "We are grateful the Supreme Court has recognized the right of states to direct taxpayer dollars toward life-affirming healthcare providers,' she said. 'No one should be forced to subsidize the abortion industry with their tax dollars.' After the Supreme Court overturned the constitutional right to abortion, South Carolina made most abortions a crime. But the state continued its legal fight to prevent Medicaid patients from receiving care at Planned Parenthood's clinics in Charleston and Columbia. Gov. Henry McMaster, who issued the ban on Planned Parenthood in 2018, said he did so to protect "his state's sovereign interests." Critics of the move said the state has a severe shortage of doctors and medical personnel who treat low-income patients on Medicaid. Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store